# OnCo record nct05050942 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05050942/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05050942", "NCT05050942" ;
  schema:name "A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET"@en ;
  schema:alternateName "SORENTO"@en ;
  schema:description "A phase 3 trial of CAM2029 (octreotide subcutaneous depot) run by Camurus AB, active."@en ;
  schema:url <https://onco.cc/trials/nct05050942/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05050942> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2021-10-22" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/pancreatic-net/>, <https://onco.cc/cancers/small-intestinal-net/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:drugs <https://onco.cc/drugs/cam2029/> ;
  onco:companies <https://onco.cc/companies/camurus/> .